TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
491,311
|
314,365
|
198,050 |
Financial expenses |
7
|
43
|
41 |
Earnings before taxes |
78,882
|
45,634
|
23,792 |
EBITDA |
77,224
|
45,958
|
24,256 |
Total assets |
360,248
|
191,588
|
139,452 |
Current assets |
358,711
|
190,171
|
137,827 |
Current liabilities |
262,235
|
131,543
|
82,673 |
Equity capital |
96,022
|
50,340
|
34,376 |
- share capital |
507
|
473
|
488 |
Employees (average) |
48
|
42
|
37 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.7%
|
26.3%
|
24.7% |
Turnover per employee |
10,236
|
7,485
|
5,353 |
Profit as a percentage of turnover |
16.1%
|
14.5%
|
12.0% |
Return on assets (ROA) |
21.9%
|
23.8%
|
17.1% |
Current ratio |
136.8%
|
144.6%
|
166.7% |
Return on equity (ROE) |
82.1%
|
90.7%
|
69.2% |
Change turnover |
154,640
|
122,267
|
-680 |
Change turnover % |
46%
|
64%
|
0% |
Chg. No. of employees |
6
|
5
|
9 |
Chg. No. of employees % |
14%
![]() |
14%
|
32% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.